gene

Gene sequencing company Illumina sells cancer test developer – The New York Times

Illumina, the leading maker of gene sequencing machines, said Sunday it would sell Grail, a cancer test developer it bought for $7.1 billion in 2021. The move came two days after Illumina lost its case in a federal appeals court that largely upheld a Federal Trade Commission decision that Illumina should terminate its contract with … [Read more…]

FDA approves two sickle cell anemia treatments, one using CRISPR gene editing – The New York Times

On Friday, the Food and Drug Administration approved the first gene-editing therapy ever used in humans to treat sickle cell anemia, a debilitating blood disorder caused by a single mutated gene. The agency also approved a second conventional gene therapy treatment for sickle cell disease that does not use gene editing. For the 100,000 sick … [Read more…]